Subscribe
ca-ssis
ca-ssis / iStockphoto.com
31 January 2019Americas

FDA approved record number of novel devices in 2018

A record number of novel devices were approved by the  US Food and Drug Administration (FDA) in 2018, the federal agency has said.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.
Americas
FDA announces new measures to boost gene therapy innovation
16 January 2019   The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.
Americas
FDA announces new measures to boost gene therapy innovation
16 January 2019   The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.

More on this story

Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.
Americas
FDA announces new measures to boost gene therapy innovation
16 January 2019   The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York